Buprenorphine and pregnancy. Analysis of 24 cases;Grossesse et buprenorphine. A propos de 24 cas

Archives de Pediatrie

Volumn 6, Issue 11, 1999, Pages 1179-1185

  Jernite, M ^a   Viville, B ^b   Escande, B ^a   Brettes, J P ^b   Messer, J ^a  

^a Service de Pédiatrie II   (France)

^b Hopital Central Strasbourg   (France)

Author keywords

Buprenorphine; Pregnancy; Substance withdrawal syndrome

Indexed keywords

BUPRENORPHINE; NARCOTIC AGENT;

ADDICTION; ADULT; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DRUG DEPENDENCE; FEMALE; FETUS DEATH; FETUS DISTRESS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAINTENANCE THERAPY; PREGNANCY; SOCIAL SUPPORT; WITHDRAWAL SYNDROME; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADULT; BUPRENORPHINE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NARCOTICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SOCIAL SUPPORT; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0033227771     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)86300-9     Document Type: Article

References (41)

1. Engasser V. Nouveau-né de mère toxicomane aux opiacés : Diagnostic et traitement du syndrome de sevrage [mémoire de doctorat en pharmacie]. Strasbourg; 1998.
2. Kandall SR, Albin S, Lowinson J, Berle B, Eidelman AI, Gartner LM. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics 1976; 58 : 681-5.
3. Dawkins JL, Tylden E, Colley N, Evans C. Drug abuse in pregnancy: Obstetric and neonatal problems. Ten years experience. Drug Alcohol Rev 1997; 16 : 25-31.
4. Blanche S, Mayaux MJ, Veber F, Landreau A, Courpotin C, Vilmer E. et al. Separation between VIH-positive women and their children. The French prospective study 1986 through 1993. Am J Public Health 1996; 86 : 376-81.
5. Parquet PJ, Bailly D, Vignau J. Servant D. Toxicomanie et grossesse, une situation nouvelle et méconnue. Sem Hop Paris 1988; 64 : 1649-54.
6. Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: Pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27 : 92-8.
7. Roudot-Thoraval F, Deforges L, Girollet PP, Maria B, Milliez J, Pathier D, et al. Prévalence des anticorps dirigés contre le virus de l'hépatite C dans une population de femmes enceintes en France. Gastroenterol Clin Biol 1992; 16 : 254-9.
8. Haber BA, Maller ES, Watkins JB. Hepatitis C virus infection in infants whose mothers took illicit drugs intravenously. J Pediatr 1991; 119 : 929-31.
9. Weintrub PS, Veereman-Wauters G, Cowman MJ, Thaler MM. Hepatitis C virus infection whose mothers took street drugs intravenously. J Pediatr 1991; 119 : 869-74.
10. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, et al. Mother to infant transmission of hepatitis C virus. Lancet 1995; 345 : 289-91.
11. Floreani A, Paternoster D, Zappala F, Cusinato R, Bombi G, Grella P, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996; 103 : 325-9.
12. Selwyn PA, Schoenbaum EE, Davenny K, Robertson VJ, Feingold AR, Shulman JF, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989; 261 : 1289-94.
13. Lejeune C, Floch-Tudal C, Montamat S, Crenn-Hebert C, Simonpoli AM. Prise en charge des femmes enceintes toxicomanes et de leurs enfants. Arch PéDiatr 1997; 4 : 263-70.
14. Boutte P, Richelme C, Berard E, Albertini M, Gillet SY, Mariani R. Le nouveau-né de mère droguée. Presse MéD 1988; 17 : 1405-8.
15. Fricker HS, Segal S. Narcotic addiction, pregnancy and the newborn. Am J Dis Child 1987; 132 : 360-6.
16. Umans JG, Szeto HH. Precipitated opiate abstinence in utero. Am J Obstet Gynecol 1985; 151 : 441-4.
17. Levy M, Spino M. Neonatal withdrawal syndrome: Associated drugs and pharmacologie management. Pharmacotherapy 1993; 13 : 202-11.
18. Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obst Gynecol 1975; 1225 : 43-6.
19. Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmaco-kinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985; 233 : 1-6.
20. Ciraru-Vigneron N, Rafowicz E, Nguyen-Tan-Lung R, Brunner C, Barrier J. Toxicomanie et grossesse : Principales conséquences obstétricales et pédiatriques. J Gynecol Obstet Biol Reprod 1989 18 : 637-48.
21. Chasnoff IJ, Burns KA, Burns WJ, Schnoll SH. Prenatal drug exposure: Effects on neonatal and infant growth and development. Neuro Behav Toxicol Teratol 1986; 8 : 357-62.
22. Dattel BJ. Substance abuse in pregnancy. Semin Perinatol 1990; 14 : 179-87.
23. Hoegerman G, Schnoll S. Narcotic use in pregnancy. Clin Perinatol 1991; 18 : 51-76.
24. Wong WM, Lao TT. Abnormal umbilical artery flow velocity waveform; A sign of fetal narcotic withdrawal? Aust N Z Obstet Gynaecol 1997; 37 : 358-9.
25. Hagopian GS, Wolfe HM, Sokol RJ, Ager JW, Wardell JN, Cepeda EE. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med 1996; 5 : 348-54.
26. Shaw NJ, McIvor L. Neonatal abstinence syndrome after maternal methadone treatment. Arch Dis Child Fetal Neonatal Ed 1994; 71 : F203-5.
27. Desmond MM, Mahzier G. Neonatal abstinence syndrome: Recognition and diagnosis. Addictive Diseases 1975; 2 : 113-21.
28. Herzlinger RA, Kandall SR, Vanghan HG. Neonatal seizures associated with narcotic withdrawal. J Pediatr 1977; 91 : 638-41.
29. Volpe JJ. Teratogenic effects of drugs and passive addiction. In: Volpe JJ, ed. Neurology of the Newborn. 3rd Ed. Philadelphia: W.S. Saunders: 1995. p. 811-50.
30. Ostrea EM Jr, Chavez CJ, Strauss M. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976; 88 : 642-5.
31. Wilson OS, Desmond MM, Wait RB. Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: Health, development and social implications. J Pediatr 1981; 98 : 716-22.
32. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81 : 936-40.
33. Kaltenbach KA. Effects of in utero opiate exposure: New paradigms for old questions. Drug Alcohol Depend 1994; 36 : 83-7.
34. Sutton LR, Hinderliter SA. Diazepam abuse in pregnant women on methadone maintenance. Implications for the neonate. Clin Pediatr 1990; 29 : 108-11.
35. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachatre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther 1997; 62 : 569-71.
36. Olofsson M, Buckley W, Andersen GE, Friis-Hansen B. Investigation of 89 children born by drug-dependent mothers. Follow-up 1-10 years after birth. Acta Paediatr Scand 1983; 72 : 407-10.
37. Oleske JM. Experience with 118 infants born to narcotic-using mothers. Clin Pediatr 1997; 16 : 418-23.
38. Davis SK. Chemical dependency in women. A description of its effects and outcome on adequate parenting. J Subst Abuse Treat 1990; 7: 225-32.
39. Cs JournéEs Parisiennes D'obstéTrique-pédiatrie. Paris: Doin; 1995. p. 33-46.
40. Ostrea EM, Chavez CJ. Perinatal problems in maternal drug addiction a study of 830 cases. J Pediatr 1979; 94 : 292-5.
41. Singer LT, Garber R, Kliegman R. Neurobehavioral sequelae of fetal cocaine exposure. J Pediatr 1991; 119 : 667-72.